Recently cleared by the FDA, Discovery PET/CT 600 is part of GE’s Discovery family of scanners designed to enable earlier detection and accurate monitoring of disease with molecular imaging technology in both hardware and software.
The Discovery PET/CT 600 leverages the high-speed, high-resolution capabilities of GE’s BrightSpeed CT with the motion management capabilities of its Discovery PET system. By combining these scanning technologies, the Discovery PET/CT 600 provides the tools to enable physicians to manage disease with more confidence, the company said.
According to the company, the Discovery PET/CT 600 offers an increased vertical scan range that provides more flexibility in radiation treatment planning and patient positioning.
Henry Hummel, general manager of GE Healthcare’s global PET/CT business, said: “Discovery PET/CT 600 is optimized for use in oncology, which represents more than 90% of clinical PET/CT exams. The Discovery PET/CT 600 platform was built for physicians and molecular imaging researchers based on their clinical need for more quantitative accuracy and the power to explore the potential of PET/CT imaging.”